New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
about
Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatmentNovel non-AR therapeutic targets in castrate resistant prostate cancerNeuropathy-inducing effects of eribulin mesylate versus paclitaxel in mice with preexisting neuropathy.Microtubule stability studied by three-dimensional molecular theory of solvationPromotion of tubulin assembly by poorly soluble taxol analogs.A novel microtubule inhibitor, MT3-037, causes cancer cell apoptosis by inducing mitotic arrest and interfering with microtubule dynamics.p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.Kinetochores and disease: keeping microtubule dynamics in check!Biochemistry and cell biology of tau protein in neurofibrillary degenerationContemporary agents in the management of metastatic castration-resistant prostate cancer.Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy.N-(4-iodophenyl)-N'-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice.Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.Inhibition of dermal MRSA colonization by microalgal micro- and nanoparticles.Targeting cell cycle kinases and kinesins in anticancer drug development.
P2860
Q28073057-82567447-D5F6-4821-91C0-7C7C0C403A28Q28383663-9E001DC4-C6FE-4948-811B-4EA210AA0AD5Q33815594-9EA68705-DCD0-4765-9159-4560237495F4Q35545459-F3D011DE-1B9C-4B32-91FC-B514B39A9EA1Q35792476-83E95351-ED86-46C7-9709-2AB4A165AAC0Q36879476-A0E4E280-7FFA-41AA-A4E8-CDA7E51E255EQ36946749-2606003D-3CF7-46E9-93A6-B14592BB47FFQ37971172-A80E73F9-5330-4B30-B0FA-98B2EB9807B4Q38023859-E15D88D2-9AFD-40D5-A14E-42BB277DB4FEQ39092924-2EA5F0FF-7B54-4655-9052-8F3AE7921592Q39327155-A9835742-1701-4AB5-8290-1C2B3C0E5F93Q40135845-93C72C03-E317-4FD6-84B4-5E511FB267CDQ40313929-FEC18D9E-2CAE-4745-B472-DD592EE41301Q44272186-D5E3F8CF-77A3-41ED-A7DF-2D2E4AB4D7BBQ52639097-E37D05F6-FC87-4088-B8A1-F31588E1957C
P2860
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@ast
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@en
type
label
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@ast
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@en
prefLabel
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@ast
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@en
P2860
P1476
New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
@en
P2093
P2860
P356
10.1179/JOC.2004.16.SUPPLEMENT-1.83
P478
16 Suppl 4
P577
2004-11-01T00:00:00Z